Skip to content
Application 021794
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ACZONE | DAPSONE | GEL;TOPICAL | 5% | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0023-3670 | ACZONE | dapsone | Allergan, Inc. | NDA | Current |
| 0023-3670 | ACZONE | dapsone | Allergan, Inc. | NDA | Current |
| 0023-3670 | ACZONE | dapsone | Allergan, Inc. | NDA | Current |
| 0023-3670 | ACZONE | dapsone | Allergan, Inc. | NDA | Current |
| 16110-367 | ACZONE | dapsone | ALMIRALL, LLC | NDA | Current |
| 16110-367 | Aczone | dapsone | Almirall, LLC | NDA | Current |
| 60758-670 | DAPSONE | dapsone | Pacific Pharma, Inc. | NDA | Current |
| 60758-670 | DAPSONE | dapsone | Pacific Pharma, Inc. | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 54283 | SUPPL | 2018-05-22 |
| 54277 | SUPPL | 2018-05-21 |
| 37659 | SUPPL | 2015-07-24 |
| 28610 | SUPPL | 2015-07-13 |
| 37658 | SUPPL | 2009-04-03 |
| 6198 | SUPPL | 2008-03-18 |
| 37657 | SUPPL | 2008-03-17 |
| 21820 | ORIG | 2007-09-13 |
| 6197 | ORIG | 2005-07-15 |
| 37656 | ORIG | 2005-07-08 |